According to a recent LinkedIn post from AppZen, many healthcare, pharma, and life sciences finance teams reportedly audit only up to 20% of their healthcare professional expense data before Open Payments filing. The post notes that this leaves a substantial gap versus the 100% accuracy required under Open Payments regulations, creating potential compliance and reporting risk.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights that even organizations outsourcing this work may be facing cost and efficiency challenges. The post suggests that finance and compliance leaders who adopt artificial intelligence tools to close this audit gap may improve risk management, cost structure, and competitive positioning in heavily regulated life sciences markets.
As shared in the post, the focus on AI-driven expense auditing appears targeted at strengthening compliance with the Sunshine Act and related transparency rules. For investors, this emphasis may indicate growing demand for automation solutions in regulatory reporting, potentially supporting AppZen’s growth prospects among large healthcare and pharmaceutical clients seeking scalable, cost-effective compliance capabilities.